BTXA (lanbotulinumtoxinA) / Sinopharm 
Welcome,         Profile    Billing    Logout  

4 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BTXA (lanbotulinumtoxinA) / Sinopharm
NCT06410859: Botulinum Toxin Type A for Injection (HengLiĀ®) in the Treatment of Trigeminal Neuralgia

Enrolling by invitation
2
240
RoW
Botulinum Toxin Type A for Injection,also known as "HengLiĀ®"
LKGS_277
Trigeminal Neuralgia
06/26
06/26
NCT06213662: Effect of Botulinum Toxin Injection Guided by Ultrasound Combined With Balloon Localization on Cricopharyngeal Achalasia

Recruiting
N/A
20
RoW
Botulinum toxin type A for injection, Botulinum toxin type A for injection (Hengli National Drug approval number S10970037)
The First Affiliated Hospital of Zhengzhou University
Cricopharyngeal Achalasia, Dysphagia
07/24
07/24
NCT06196606: Effect of Botulinum Toxin Injection Into Upper Esophageal Sphincter in Patients With Medullary Infarction

Recruiting
N/A
20
RoW
Botulinum toxin type A for injection, Botulinum toxin type A for injection (Hengli National Drug approval number S10970037)
The First Affiliated Hospital of Zhengzhou University
Brain Stem Infarctions, Dysphagia, Oropharyngeal, Dysphagia, Esophageal
12/24
12/24
ChiCTR2200064222: Botulinum toxin A injection in the prevention of cicatricial hyperplasia of facial surgical incision: A prospective, group controlled, randomized, double-blind trial

Not yet recruiting
N/A
120
 
Botulinum toxin type A (normal saline diluted to 25Units/ml, lanzhou hengli) was injected immediately after surgical suture, and the injection dose was 1Unit per 1mm wound, 0.5cm away from the wound ;Inject the appropriate amount of saline
Shanghai Ninth People's Hospital, Shanghai Jiaotong University School Of Medicine; Shanghai Ninth People's Hospital, Shanghai Jiaotong University School Of Medicine, Lanzhou Biotechnique Development Co., Ltd.
Scar
 
 

Download Options